Education
About Us
Working with TipRanks
Follow Us
Quoin Pharmaceuticals (QNRX)
NASDAQ:QNRX
Total Valuation
Quoin Pharmaceuticals has a market cap or net worth of $4.34M. The enterprise value is -$7.64M.
Market Cap$4.34M
Enterprise Value-$7.64M
Share Statistics
Quoin Pharmaceuticals has 588,167 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding588,167
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Quoin Pharmaceuticals’s return on equity (ROE) is -0.98 and return on invested capital (ROIC) is -0.08%.
Return on Equity (ROE)-0.98
Return on Assets (ROA)-0.57
Return on Invested Capital (ROIC)-0.08%
Return on Capital Employed (ROCE)-0.83
Revenue Per Employee0.00
Profits Per Employee-3.00M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Quoin Pharmaceuticals is ―. Quoin Pharmaceuticals’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value<0.01
Price to FCF―
Price to Operating Cash Flow-0.39
PEG Ratio―
Income Statement
In the last 12 months, Quoin Pharmaceuticals had revenue of 0.00 and earned -9.01M in profits. Earnings per share was -67.17.
Revenue0.00
Gross Profit-100.47K
Operating Income-9.57M
Pretax Income-8.96B
Net Income-9.01M
EBITDA-8.90M
Earnings Per Share (EPS)-67.17
Cash Flow
In the last 12 months, operating cash flow was -10.70M and capital expenditures 0.00, giving a free cash flow of -10.70M billion.
Operating Cash Flow-10.70M
Free Cash Flow-10.70M
Free Cash Flow per Share-18.19
Dividends & Yields
Quoin Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.28
52-Week Price Change-64.05%
50-Day Moving Average8.10
200-Day Moving Average12.12
Relative Strength Index (RSI)47.28
Average Volume (3m)3.97K
Important Dates
Quoin Pharmaceuticals upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Quoin Pharmaceuticals as a current ratio of 3.57, with Debt / Equity ratio of 0.00%
Current Ratio3.57
Quick Ratio3.57
Debt to Market Cap6.88
Net Debt to EBITDA0.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Quoin Pharmaceuticals has paid -8.95B in taxes.
Income Tax-8.95B
Effective Tax Rate1.00
Enterprise Valuation
Quoin Pharmaceuticals EV to EBITDA ratio is 0.07, with an EV/FCF ratio of 0.08.
EV to Sales0.00
EV to EBITDA0.07
EV to Free Cash Flow0.08
EV to Operating Cash Flow0.08
Balance Sheet
Quoin Pharmaceuticals has $1.67M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$1.67M billion.
Cash & Marketable Securities$1.67M
Total Debt$0.00
Net Cash-$1.67M
Net Cash Per Share-$2.84
Tangible Book Value Per Share$65.10
Margins
Gross margin is -25.19%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-25.19%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Quoin Pharmaceuticals is $70.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$70.00
Price Target Upside833.33% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast-146.64%